Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Past Funding Opportunities

right

Artificial Intelligence Molecular Screen (AIMS) Awards

Deadline: 
Monday, December 14, 2020 - 5:00pm

Why did Atomwise create this award?
The goal of this program is to broaden the pool of scientists pursuing drug discovery. To advance this goal, Atomwise will award researchers with a customized virtual screen using cutting-edge Artificial Intelligence (AI) technology, approximately 72 chemical compounds for physical screening, and technical support from medicinal chemists and computational biologists.

right

Emerson Collective Clinical Research Award

Deadline: 
Friday, November 13, 2020 - 5:00pm

 

 

Emerson Collective seeks to fund collaborative clinical research focused on populations with unequal burdens of colorectal cancer (CRC) by exploring the association between molecular characteristics such as tumor mutation and clinical characteristics such as disease stage, recurrence rate, and overall survival. 

right

Cyclica Academic Partnership Program

Deadline: 
Saturday, October 31, 2020 - 5:00pm

 

 

Cyclica is an AI-based drug discovery company that has developed a structure-based, AI-augmented in silico drug discovery platform. CAPP is an opportunity for academic investigators to apply for in-kind access to Cyclica’s drug development platforms. The program offers two types of awards: 

Ligand Design Award: to generate novel compounds for your target of interest

right

Columbia Life Science Lab-to-Market Accelerators

Deadline: 
Friday, November 20, 2020 - 5:00pm

Are you interested in bringing your life science innovations to life? The Columbia Life Science Accelerator programs help translate cutting-edge faculty-led university research out of the lab through project funding, education, and support for interdisciplinary teams working to advance innovative ideas with the potential to positively impact health outcomes.

The 2020-2021 cycle focuses on:

Therapeutics/Drug Development

right

Columbia-NYU-Takeda Alliance Request for Proposals

Deadline: 
Monday, July 27, 2020 - 5:00pm

Columbia University, New York University, and Takeda Pharmaceuticals have formed a collaborative research alliance to initiate and advance gastroenterology (GI) research programs with high potential to impact the development of new therapeutics for patients with GI disorders. Takeda is a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.

right

Pfizer’s Centers for Therapeutic Innovation Requests Proposals for Therapeutic Targets (Large Molecule Programs Only)

Deadline: 
Monday, September 21, 2020 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.

right

COVID-19 Funding Opportunities (via Columbia Research)

Deadline: 
Thursday, December 31, 2020 - 3:15pm
Click here for a list of of COVID-19 Funding Opportunities compiled by Columbia Research.
right

ADDF-Harrington Scholar Awards

Deadline: 
Monday, May 18, 2020 - 5:00pm
Overview:
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute® (HDI) have partnered to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias.

Pages